News Sentiment

PLRX sentiment intelligence

Pliant Therapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 51 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 1.15 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

80/100 classification confidence.

Company focus 42

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend inactive

+2.7% over one week, -0.9% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Form 4 Pliant Therapeutics Inc For: 13 July By Investing.com

Market Reaction

Balanced read

62/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 80/100 classification
One-week reaction 2.7% Price confirming higher
Trend fit Trend inactive -0.9% over four weeks
Fair value -85.8% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 10
Neutral 37
Negative 4

Relevance

Why the article matched

Direct first
Direct company coverage 42
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
TradingView 12
Stock Titan 9
TradingKey 7
Market source 6
GlobeNewswire 3
dars.gov.et 2
simplywall.st 2
MarketBeat 2

Event Lens

What the news is about

Classified themes
Market update 28
Earnings 18
Regulatory and legal 2
Analyst action 1
Capital return 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-51 of 51
TradingKey Direct company coverage

Pliant Therapeutics Inc (PLRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Pliant Therapeutics Inc (PLRX), detailing its price momentum, support and resistance levels, and indicator readings. The stock currently has a price momentum score of 3.93, suggesting it's suitable for range-bound swing trading betwee

Tone
Negative 39/100
Event
Market update
Published
16 Jun 2026 22:11
Source
TradingKey